-
Mashup Score: 0Study identifies benefits, risks linked to popular weight-loss drugs | WashU Medicine - 4 hour(s) ago
GLP-1 medications tied to decreased risk of dementia, addiction; increased risk of kidney, pancreas and gastrointestinal problems
Source: medicine.washu.eduCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 3Birthplace of precision medicine - Outlook Magazine - 4 hour(s) ago
Together, WashU Medicine and Siteman Cancer Center have long been a powerhouse in cancer research and a national leader in providing innovative, compassionate care to patients while pushing the boundaries of what’s possible in treating this ancient and ever-evolving disease. Our researchers and clinicians are poised to shape future decades of cancer advances after having […]
Source: outlook.washu.eduCategories: General Medicine News, Oncologists1Tweet-
WashU Medicine researchers have led the field of cancer genomics since its inception. Their work has advanced a personalized approach for patients, creating a standard of care at @SitemanCenter that's been adopted nationally and has led to better outcomes: https://t.co/zbSXOEw8vP https://t.co/cqxvEgvAHn
-
-
Mashup Score: 2
Study also finds socioeconomic status linked to brain health in adults
Source: medicine.washu.eduCategories: General Medicine News, Oncologists1Tweet-
A new brain imaging study helps explain challenges experienced by people with sickle cell disease, such as a higher risk for stroke and resulting cognitive disability. https://t.co/BoiSykht8n
-
-
Mashup Score: 1Drug in clinical trials for breast cancer could also treat some blood cancers | WashU Medicine - 5 day(s) ago
Researchers are working with industry toward a clinical trial for blood cancer patients
Source: medicine.washu.eduCategories: General Medicine News, Oncologists1Tweet-
Two new studies led by researchers at WashU Medicine have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials against breast cancer. https://t.co/rOnLj9t9Jr
-
-
Mashup Score: 2
Gene therapy, in mice modeling Batten disease, found to slow symptoms, extend lifespan
Source: medicine.washu.eduCategories: General Medicine News, Oncologists1Tweet-
Jonathan D. Cooper, PhD, thought little about the gastrointestinal system. That is, until the parents of children with Batten disease urged him to investigate why debilitating digestive issues troubled their kids. https://t.co/nkjmspTqUd
-
-
Mashup Score: 8New cellular immunotherapy approach shows promise for B-cell lymphoma | WashU Medicine - 8 day(s) ago
Off-the-shelf CAR-natural killer cells could expand accessibility, reduce cost of cell-based cancer therapies
Source: medicine.washu.eduCategories: General Medicine News, Oncologists1Tweet-
A new cellular immunotherapy approach shows promise for B-cell lymphomas and — due to innovations in manufacturing — could make future cellular immunotherapies less expensive and more accessible to patients. https://t.co/756zPGWOPd
-
-
Mashup Score: 45Mwirigi awarded HHMI fellowship for exceptional early-career scientists | WashU Medicine - 14 day(s) ago
Postdoctoral neuroscientist receives multiyear support for research on chronic pain
Source: medicine.washu.eduCategories: General Medicine News, Oncologists1Tweet-
Neuroscientist Juliet Mwirigi, PhD, a postdoctoral researcher at WashU Medicine, has been named a Hanna H. Gray Fellow by the Howard Hughes Medical Institute @HHMINEWS. https://t.co/tuLhu7mbap
-
-
Mashup Score: 4
Study may lead to personalized prevention, management tools for post-operative pain
Source: medicine.washu.eduCategories: General Medicine News, Oncologists1Tweet-
WashU Medicine has received a $5 million NIH grant to find causes of chronic pain after surgery. This study may lead to personalized prevention and management tools for post-operative pain. https://t.co/ARI442e3sC
-
-
Mashup Score: 0Innovation by collaboration - Outlook Magazine - 1 month(s) ago
Brain tumors are among the most challenging cancers to effectively treat. Depending on the tumor’s location, surgery can interfere with cognitive function, movement or language, and surgery often is not the solution because the tumor cells are invasive and intertwined with normal brain cells. Additionally, the brain’s natural protective barrier prevents chemotherapy drugs from reaching […]
Source: outlook.washu.eduCategories: General Medicine News, Oncologists1Tweet-
Brain tumors are among the most challenging cancers to effectively treat. WashU Medicine physicians and researchers at Siteman Brain Tumor Center have joined forces to develop a program focused on new therapeutics to help improve patient survival. https://t.co/WpM0JGvnFP https://t.co/VEbfj9obPX
-
-
Mashup Score: 1
Research will look for early warning signs, potential treatment of second-leading cause of dementia
Source: medicine.washu.eduCategories: General Medicine News, Oncologists1Tweet-
WashU Medicine has received a $7.5M NIH grant to study cerebral small vessel disease, the second-leading cause of dementia. The research will use advanced imaging and multi-omic technologies to identify biomarkers and drug targets for potential treatments. https://t.co/P6YOSmsjkg
-
Demand for weight-loss medications continues to surge, with a recent study of 2M+ Americans showing benefits including cognitive and behavioral health. However, GLP-1RAs are also presenting negative side effects such as GI and kidney problems. https://t.co/g8QciqCcZY